Company performance
Current Price
as of Jan 21, 2025$2.07
P/E Ratio
N/A
Market Cap
$51.08M
- CGA
Description
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. It operates through the Healthcare, Infusion Technology and Real Estate segments. The Healthcare segment relates to the activities of LipoMedix, Barer, Farber, and Rafael Medical Devices. The company was founded in 2017 and is headquartered in Newark, NJ.
Metrics
Overview
- HQNewark, NJ
- SectorFinance
- IndustryReal Estate Development
- TickerRFL
- Price$2.07+2.99%
Trading Information
- Market cap$51.08M
- Float75.44%
- Average Daily Volume (1m)42,280
- Average Daily Volume (3m)31,912
- EPS-$1.67
Company
- Revenue$0.70M
- Rev growth (1yr)88.24%
- Net income-$9.01M
- Gross margin3.91%
- EBITDA margin-2,935.94%
- EBITDA-$3.76M
- EV-$3.52M
- EV/Revenue-5.06
- P/EN/A
- P/S71.46
- P/B0.69
Documents
SEC Filings